首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF CINITAPRIDE IN PURE AND IN ITS PHARMACEUTICAL FORMULATION
【24h】

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF CINITAPRIDE IN PURE AND IN ITS PHARMACEUTICAL FORMULATION

机译:分光光度法测定纯及其药物配方中烟碱的测定方法的建立和验证

获取原文
获取外文期刊封面目录资料

摘要

Two simple, sensitive, accurate and economical spectrophotometric methods (A and B) were developed for the determination of cinitapride in pure and in pharmaceutical formulation. Method A is based on the reaction of the nitro group of the drug with potassium hydroxide in dimethyl sulphoxide medium to form a colored product, which shows absorbance maximum at 401 nm. Method B is based on the diazotization of cinitapride with nitrous acid to form diazotized cinitapride, followed by its coupling with β-naphthol to form a red colored chromogen which shows maximum absorption at 552 nm. Beer’s law is obeyed in the concentration range of 10–50 μg mL–1 for method A and 1-5 μg mL–1 for method B. Correlation coefficient was found to be 0.999 for both methods. The methods have been successfully applied for the assay of the drug in pure and in pharmaceutical formulation. No interference was observed from common pharmaceutical additives. The developed methods were validated respect to linearity, precision, LOD, LOQ and accuracy.
机译:开发了两种简单,灵敏,准确和经济的分光光度法(A和B),用于测定纯制剂和药物制剂中的西那肽。方法A基于药物的硝基与氢氧化钾在二甲基亚砜介质中反应形成有色产物,该产物在401 nm处显示最大吸收。方法B的基础是用亚硝酸将西尼哌肽重氮化以形成重氮化的西尼哌肽,然后将其与β-萘酚偶联形成红色色原,在552 nm处显示最大吸收。方法A的浓度范围为10–50μgmL–1,方法B的浓度范围为1-5μgmL–1,遵守比尔定律。两种方法的相关系数均为0.999。该方法已成功应用于纯药物制剂和药物制剂中的药物分析。没有观察到来自普通药物添加剂的干扰。所开发的方法在线性,精度,LOD,LOQ和准确性方面得到了验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号